[Image courtesy of FDA]
1. Startups and strategics are expanding beyond episodic care and procedures.
“Companies that have historically targeted specific therapeutic areas defined by a procedure (e.g., implanted devices) are adding products and solutions to their portfolios to help address the full patient journey — from diagnosis to rehabilitation,” the report said. “Nearly half of startups (46%) have a focus on prevention and/or wellness or detection/diagnosis, and only 19% include a focus on treatment.”
Deloitte warns of pressure on the traditional medtech business model from this trend, but sees potential for a substantial new medtech market out of startups focused on disease detection and prevention that will probably include sensor-driven, regulated medical devices.
Cardiology was the most common clinical area identified by startups in prevention/wellness.
